Go to content

Publications

257 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period
—

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Obeticholic acid (Ocaliva®) for the treatment of primary biliary cholangitis

Zorginstituut Nederland carried out an assessment of whether obeticholic acid (Ocaliva®) is interchangeable with a drug currently ...

Report | 18-07-2018

Cariprazine (Reagila®) for the treatment of schizophrenia

The Minister of Health, Welfare and Sport (WVS) asked Zorginstituut Nederland (National Health Care Institute) to carry out a ...

Report | 04-06-2018

Dimethyl fumarate (Skilarence®) for the treatment of plaque psoriasis in adults

The Minister of Health, Welfare and Sport (WVS) asked Zorginstituut Nederland (National Health Care Institute) to carry out an ...

Report | 09-05-2018

Flash Glucose Monitoring (FGM)

In this report Zorginstituut Nederland (National Health Care Institute) assesses whether Flash Glucose Monitoring (FGM) complies ...

Report | 30-04-2018

Rolapitant (Varuby®) for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults

Zorginstituut Nederland has carried out an assessment of the medicinal product rolapitant (Varuby®). The GVS report concludes ...

Report | 17-04-2018

Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)

Zorginstituut Nederland has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and a ...

Report | 29-03-2018

Fampridine (Fampyra®) in cases of multiple sclerosis (MS)

Zorginstituut Nederland carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the outcomes of the ...

Report | 01-03-2018

Nusinersen (Spinraza®) for the treatment of 5q Spinal Muscular Atrophy

Zorginstituut Nederland carried out an assessment on the medicinal product nusinersen (Spinraza®) for the treatment of 5q Spinal ...

Report | 07-02-2018

Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia

Zorginstituut Nederland issued a package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...

Report | 18-01-2018

Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis

Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL ...

Report | 04-01-2018

Go to